Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GeneDx Holdings (WGS) Interest Expenses (2020 - 2023)

GeneDx Holdings has reported Interest Expenses over the past 4 years, most recently at $626000.0 for Q2 2023.

  • Quarterly Interest Expenses fell 20.76% to $626000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $626000.0 through Mar 2024, down 80.23% year-over-year, with the annual reading at $3.2 million for FY2022, 13.12% up from the prior year.
  • Interest Expenses was $626000.0 for Q2 2023 at GeneDx Holdings, down from $767000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $808000.0 in Q1 2022 and troughed at $626000.0 in Q2 2023.
  • The 4-year median for Interest Expenses is $722500.0 (2021), against an average of $726666.7.
  • Year-over-year, Interest Expenses increased 18.01% in 2022 and then fell 20.76% in 2023.
  • A 4-year view of Interest Expenses shows it stood at $648000.0 in 2020, then grew by 9.1% to $707000.0 in 2021, then rose by 13.58% to $803000.0 in 2022, then fell by 22.04% to $626000.0 in 2023.
  • Per Business Quant, the three most recent readings for WGS's Interest Expenses are $626000.0 (Q2 2023), $767000.0 (Q1 2023), and $803000.0 (Q4 2022).